Stifel Financial’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.8M | Sell |
93,060
-15,193
| -14% | -$4.11M | 0.02% | 555 |
|
|
2025
Q4 | $27.2M | Sell |
108,253
-10,016
| -8% | -$2.66M | 0.02% | 525 |
|
|
2025
Q3 | $34M | Sell |
118,269
-8,797
| -7% | -$2.36M | 0.03% | 459 |
|
|
2025
Q2 | $33.4M | Sell |
127,066
-2,753
| -2% | -$670K | 0.03% | 439 |
|
|
2025
Q1 | $30.2M | Sell |
129,819
-479,125
| -79% | -$116M | 0.03% | 437 |
|
|
2024
Q4 | $140M | Buy |
608,944
+14,437
| +2% | +$3.31M | 0.15% | 153 |
|
|
2024
Q3 | $133M | Buy |
594,507
+8,313
| +1% | +$1.83M | 0.14% | 160 |
|
|
2024
Q2 | $119M | Buy |
586,194
+3,049
| +0.5% | +$620K | 0.13% | 160 |
|
|
2024
Q1 | $127M | Buy |
583,145
+12,958
| +2% | +$2.85M | 0.15% | 154 |
|
|
2023
Q4 | $130M | Buy |
570,187
+21,222
| +4% | +$4.46M | 0.16% | 142 |
|
|
2023
Q3 | $110M | Sell |
548,965
-39,138
| -7% | -$8.26M | 0.16% | 146 |
|
|
2023
Q2 | $122M | Buy |
588,103
+25,454
| +5% | +$4.94M | 0.17% | 137 |
|
|
2023
Q1 | $111M | Buy |
562,649
+20,116
| +4% | +$4.14M | 0.16% | 145 |
|
|
2022
Q4 | $110M | Buy |
542,533
+19,095
| +4% | +$3.73M | 0.16% | 145 |
|
|
2022
Q3 | $92.1M | Buy |
523,438
+26,977
| +5% | +$5.52M | 0.15% | 156 |
|
|
2022
Q2 | $100M | Buy |
496,461
+8,496
| +2% | +$1.81M | 0.16% | 146 |
|
|
2022
Q1 | $111M | Buy |
487,965
+19,205
| +4% | +$4.52M | 0.15% | 158 |
|
|
2021
Q4 | $127M | Buy |
468,760
+19,806
| +4% | +$4.9M | 0.17% | 137 |
|
|
2021
Q3 | $109M | Buy |
448,954
+10,214
| +2% | +$2.57M | 0.16% | 141 |
|
|
2021
Q2 | $104M | Buy |
438,740
+6,234
| +1% | +$1.42M | 0.16% | 151 |
|
|
2021
Q1 | $94.8M | Buy |
432,506
+23,039
| +6% | +$4.62M | 0.16% | 142 |
|
|
2020
Q4 | $71.6M | Buy |
409,467
+20,932
| +5% | +$3.62M | 0.13% | 167 |
|
|
2020
Q3 | $62.8M | Buy |
388,535
+32,501
| +9% | +$5.15M | 0.13% | 166 |
|
|
2020
Q2 | $50.8M | Buy |
356,034
+61,338
| +21% | +$8.49M | 0.12% | 182 |
|
|
2020
Q1 | $32.1M | Buy |
294,696
+231,543
| +367% | +$33.4M | 0.09% | 218 |
|
|
2019
Q4 | $9.19M | Buy |
63,153
+614
| +1% | +$88.6K | 0.02% | 640 |
|
|
2019
Q3 | $9.04M | Buy |
62,539
+3,460
| +6% | +$505K | 0.02% | 598 |
|
|
2019
Q2 | $8.77M | Sell |
59,079
-10,974
| -16% | -$1.53M | 0.02% | 628 |
|
|
2019
Q1 | $9.19M | Buy |
70,053
+3,899
| +6% | +$480K | 0.03% | 563 |
|
|
2018
Q4 | $7.18M | Buy |
66,154
+2,063
| +3% | +$276K | 0.02% | 597 |
|
|
2018
Q3 | $9.56M | Sell |
64,091
-517
| -0.8% | -$78.6K | 0.03% | 561 |
|
|
2018
Q2 | $9.95M | Buy |
64,608
+781
| +1% | +$118K | 0.03% | 541 |
|
|
2018
Q1 | $8.87M | Buy |
63,827
+5,974
| +10% | +$878K | 0.03% | 572 |
|
|
2017
Q4 | $7.93M | Sell |
57,853
-1,399
| -2% | -$185K | 0.03% | 611 |
|
|
2017
Q3 | $7.69M | Buy |
59,252
+856
| +1% | +$114K | 0.03% | 594 |
|
|
2017
Q2 | $7.73M | Buy |
58,396
+2,139
| +4% | +$262K | 0.03% | 571 |
|
|
2017
Q1 | $6.92M | Sell |
56,257
-309
| -0.5% | -$36.6K | 0.03% | 579 |
|
|
2016
Q4 | $6.24M | Buy |
56,566
+1,778
| +3% | +$198K | 0.03% | 579 |
|
|
2016
Q3 | $6.47M | Sell |
54,788
-23,891
| -30% | -$2.82M | 0.03% | 540 |
|
|
2016
Q2 | $8.81M | Buy |
78,679
+5,161
| +7% | +$555K | 0.04% | 404 |
|
|
2016
Q1 | $7.39M | Buy |
73,518
+21,555
| +41% | +$2.07M | 0.04% | 404 |
|
|
2015
Q4 | $5.52M | Buy |
51,963
+5,240
| +11% | +$541K | 0.03% | 519 |
|
|
2015
Q3 | $4.35M | Sell |
46,723
-1,787
| -4% | -$185K | 0.02% | 568 |
|
|
2015
Q2 | $5.04M | Sell |
48,510
-25,037
| -34% | -$2.61M | 0.03% | 571 |
|
|
2015
Q1 | $7.97M | Buy |
73,547
+45,725
| +164% | +$4.7M | 0.04% | 467 |
|
|
2014
Q4 | $2.58M | Buy |
27,822
+8,139
| +41% | +$719K | 0.01% | 798 |
|
|
2014
Q3 | $1.72M | Buy |
19,683
+2,571
| +15% | +$232K | 0.02% | 822 |
|
|
2014
Q2 | $1.51M | Buy |
17,112
+2,683
| +19% | +$232K | 0.01% | 903 |
|
|
2014
Q1 | $1.22M | Buy |
+14,429
| New | +$1.15M | 0.01% | 965 |
|
Other funds holding LH
VCM
VPM
Stifel Financial's LH Position: Q1 2026 in Review
Stifel Financial reduced its Labcorp (LH) stake by 14% in Q1 2026, selling an estimated $4.11M and leaving 93,060 shares worth $24.8M. The position accounts for 0.02% of the portfolio, ranked #555.
Stifel Financial first reported a position in LH in Q1 2014 and has held it in 49 quarters since. The position peaked at $140M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Stifel Financial held 93,060 shares of Labcorp worth $24.8M as of Q1 2026.
- Stifel Financial sold 15,193 Labcorp shares in Q1 2026, an estimated $4.11M.
- Labcorp made up 0.02% of Stifel Financial's portfolio in Q1 2026, its #555 holding.
- Stifel Financial first reported a position in Labcorp in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Labcorp position peaked at $140M in Q4 2024.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.